Menarini Silicon Biosystems has signed an agreement for the acquisition of the CELLSEARCH CTC business from American company Janssen Diagnostics LLC. At the moment of closing, the ownership of the only system already cleared by the Food and Drug Administration and CE marked for detecting Circulating Tumor Cells (CTC) in cancer patients starting from a liquid biopsy, will pass into the hands of Menarini Silicon Biosystems.
Web Content Display
2018
)
March 22, 2018
)
March 12, 2018
2017
)
September 28, 2017
)
September 11, 2017
)
March 13, 2017
)
January 19, 2017
2016
)
December 6, 2016
)
October 19, 2016
2014
)
November 25, 2014
)
June 20, 2014
2013
)
November 8, 2013
2012
)
December 7, 2012
2011
)
November 15, 2011
)
February 16, 2011
)
January 15, 2011
